The United States vaccine injury compensation system is grappling with significant challenges in handling claims tied to COVID-19 vaccines.
The House Select Subcommittee on the Coronavirus Pandemic warns that without major reforms, clearing the backlog in the Countermeasures Injury Compensation Program (CICP) could take almost 10 years, revealing significant system inefficiencies.
The CICP, designed to handle emergencies on a smaller scale, has struggled to adapt to the demands of a global vaccination effort. According to a report from the Select Subcommittee on the Coronavirus Pandemic, “The current backlog would take nearly a decade to eliminate without accounting for any new claims.”
Critics argue that the program lacks both the capacity and transparency to function effectively. Unlike the better-funded National Vaccine Injury Compensation Program (VICP), the CICP offers limited benefits, no appeals process and less public accountability.
The subcommittee’s report sheds light on the program’s inability to meet the demands of the COVID-19 pandemic. It highlights inefficiencies in processing claims and calls for systemic changes.
“The Countermeasures Injury Compensation Program failed to handle a mass-vaccination program,” the report states, recommending that claims related to COVID-19 vaccines be transitioned to the VICP.
Joe Raedle/Getty Images
With its broader coverage and established legal framework, this program could provide a more effective mechanism for addressing vaccine-related injuries.
The report also emphasizes the need for significant investments to enhance the system. Suggested reforms include increasing funding and staffing for the CICP to reduce delays, adopting advanced technology to streamline application reviews, and improving coordination with data systems like the Vaccine Adverse Event Reporting System (VAERS).
Transparency is another critical area for improvement. The report stresses that secrecy in claim handling undermines public trust, stating, “Transparency is not a luxury but a necessity for public confidence.”
Mishandling claims risks eroding trust in vaccines and public health institutions. The report warns that delays and a lack of accountability could discourage participation in future vaccination campaigns. It also urges policymakers to ensure that discussing vaccine injury compensation is not conflated with anti-vaccine sentiment.
“Debating or discussing vaccine injury compensation is not ‘anti-vax,’ and implications otherwise are counterproductive to protecting public health,” it notes.
The subcommittee’s findings are clear: without reform, the current system will continue to fail claimants and weaken public confidence. Addressing the backlog and improving transparency are essential steps to restore trust.
The report concludes with a call for action: “Accountability, transparency, honesty, and integrity will regain this trust.” These changes are not just about addressing past failures but ensuring the country is better prepared for future public health challenges.